TNYA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 32.76%

Insider Buying (Last 12 Months): $9,999,999.00

Insider Selling (Last 12 Months): $184,121.67

Tenaya Therapeutics Insider Trading History Chart

Tenaya Therapeutics Share Price & Price History

^$2.06

▲ +0.09 (4.57%)

As of 11/18/2024 01:00 AM ET

Days: 30 | 90 | 365

This company will win the AI race

From Porter & Company | Ad

Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence. And without it, the entire AI industry would collapse.

You must read this new presentation from Porter Stansberry.

Tenaya Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/18/2024	Chihiro Saito	SVP	Sell	2,258	$2.12	$4,786.96	60,983
8/16/2024	Chihiro Saito	SVP	Sell	2,363	$2.89	$6,829.07	63,241
8/16/2024	Faraz Ali	CEO	Sell	9,748	$2.89	$28,171.72	188,331
8/16/2024	Whittemore Tingley	Insider	Sell	7,428	$2.89	$21,466.92	107,106
3/5/2024	Timothy Hoey	Insider	Sell	3,300	$7.00	$23,100.00	245,346
2/20/2024	Timothy Hoey	Insider	Sell	6,569	$5.34	$35,078.46	236,146
2/16/2024	Faraz Ali	CEO	Sell	6,358	$5.86	$37,257.88	113,079
2/16/2024	Timothy Hoey	Insider	Sell	4,681	$5.86	$27,430.66	242,715
2/12/2024	Group Gp Lp Column III	Major Shareholder	Buy	2,222,222	$4.50	$9,999,999.00	13,599,275
8/29/2023	Timothy Hoey	Insider	Sell	7,243	$4.26	$30,855.18	247,396
8/16/2023	Faraz Ali	CEO	Sell	5,563	$3.81	$21,195.03	119,437
8/16/2023	Timothy Hoey	Insider	Sell	4,007	$3.81	$15,266.67	254,639
3/10/2023	Group Gp Lp Column III	Major Shareholder	Buy	6,779	$2.60	$17,625.40	11,377,053
2/8/2023	David V Goeddel	Director	Buy	1,500,000	$2.60	$3,900,000.00	11,370,274
1/19/2023	Group Gp Lp Column III	Major Shareholder	Buy	69,739	$2.50	$174,347.50	9,870,274
1/18/2023	David V Goeddel	Director	Buy	135,688	$2.52	$341,933.76	9,800,535
1/17/2023	Group Gp Lp Column III	Major Shareholder	Buy	49,463	$2.49	$123,162.87	9,664,847
11/21/2022	Deepak Srivastava	Director	Buy	230,769	$2.60	$599,999.40	372,435
11/17/2022	Eli Casdin	Director	Buy	2,492,042	$2.60	$6,479,309.20	6,078,860
4/26/2022	Timothy Hoey	Insider	Sell	1,353	$10.13	$13,705.89	198,646

Urgent: This election is rigged

From Porter & Company | Ad

If you missed it, my emergency election broadcast is now available - but will be removed soon

Click here to watch it now.

SEC Filings (Institutional Ownership Changes) for Tenaya Therapeutics (NASDAQ:TNYA)

90.54% of Tenaya Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Tenaya Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/16/2024	Geode Capital Management LLC	1,296,156	$2.50M	0.0%	+5.4%	1.636%
11/15/2024	XTX Topco Ltd	49,290	$95K	0.0%	+51.2%	0.062%
11/15/2024	Jane Street Group LLC	30,806	$59K	0.0%	-52.1%	0.039%
11/15/2024	Wellington Management Group LLP	294,133	$0.57M	0.0%	+35.6%	0.371%
11/15/2024	State Street Corp	1,058,898	$2.04M	0.0%	+0.9%	1.337%
11/15/2024	RA Capital Management L.P.	6,982,587	$13.48M	0.2%	-8.4%	8.814%
11/15/2024	Jacobs Levy Equity Management Inc.	337,265	$0.65M	0.0%	+204.4%	0.426%
11/14/2024	Walleye Capital LLC	69,479	$0.13M	0.0%	N/A	0.088%
11/13/2024	FMR LLC	1,345,938	$2.60M	0.0%	+1.9%	1.699%
11/6/2024	Cornercap Investment Counsel Inc.	30,222	$58K	0.0%	-52.7%	0.038%
11/5/2024	GSA Capital Partners LLP	147,932	$0.29M	0.0%	-18.7%	0.188%
10/25/2024	abrdn plc	550,700	$1.06M	0.0%	N/A	0.698%
10/3/2024	SG Americas Securities LLC	25,493	$49K	0.0%	N/A	0.032%
8/16/2024	Algert Global LLC	23,837	$74K	0.0%	N/A	0.030%
8/15/2024	The Manufacturers Life Insurance Company	23,199	$72K	0.0%	+43.2%	0.030%
8/15/2024	AQR Capital Management LLC	13,978	$43K	0.0%	-26.1%	0.018%
8/14/2024	Squarepoint Ops LLC	120,704	$0.37M	0.0%	+86.0%	0.154%
8/14/2024	Integral Health Asset Management LLC	2,325,000	$7.21M	0.7%	+3.3%	2.947%
8/9/2024	Renaissance Technologies LLC	157,460	$0.49M	0.0%	+144.1%	0.201%
8/9/2024	Dimensional Fund Advisors LP	102,026	$0.32M	0.0%	+42.5%	0.130%
8/8/2024	American Century Companies Inc.	102,114	$0.32M	0.0%	+27.7%	0.130%
8/6/2024	Acadian Asset Management LLC	11,862	$36K	0.0%	-93.4%	0.015%
8/1/2024	Rhumbline Advisers	78,160	$0.24M	0.0%	+10.5%	0.100%
7/29/2024	Panagora Asset Management Inc.	52,744	$0.16M	0.0%	N/A	0.067%
7/26/2024	Bank of New York Mellon Corp	237,597	$0.74M	0.0%	+12.3%	0.303%
7/17/2024	Atticus Wealth Management LLC	30,563	$95K	0.0%	-45.9%	0.039%
5/17/2024	RA Capital Management L.P.	5,755,050	$30.10M	0.4%	+4.5%	7.329%
5/16/2024	Jacobs Levy Equity Management Inc.	168,565	$0.88M	0.0%	+90.8%	0.215%
5/15/2024	Price T Rowe Associates Inc. MD	3,346,522	$17.50M	0.0%	-26.4%	4.262%
5/10/2024	Acadian Asset Management LLC	179,132	$0.94M	0.0%	-39.2%	0.228%
5/10/2024	Vanguard Group Inc.	2,862,916	$14.97M	0.0%	+16.4%	3.646%
5/7/2024	SG Americas Securities LLC	16,194	$85K	0.0%	-36.1%	0.021%
5/3/2024	GSA Capital Partners LLP	224,051	$1.17M	0.1%	-52.4%	0.285%
4/17/2024	Atticus Wealth Management LLC	56,512	$0.30M	0.1%	-18.5%	0.072%
3/26/2024	HighPoint Advisor Group LLC	70,390	$0.23M	0.0%	N/A	0.090%
2/13/2024	NEOS Investment Management LLC	62,159	$0.20M	0.0%	N/A	0.091%
2/2/2024	Bailard Inc.	32,900	$0.11M	0.0%	N/A	0.048%
1/30/2024	Cornercap Investment Counsel Inc.	81,255	$0.26M	0.0%	+136.2%	0.119%
1/25/2024	Redwood Wealth Management Group LLC	16,350	$53K	0.1%	+38.0%	0.024%
1/19/2024	Denali Advisors LLC	43,300	$0.14M	0.0%	-15.3%	0.064%
1/17/2024	Atticus Wealth Management LLC	69,324	$0.23M	0.1%	-13.4%	0.102%
1/12/2024	SG Americas Securities LLC	25,337	$82K	0.0%	+20.0%	0.037%
12/1/2023	Euclidean Capital LLC	1,015,705	$2.59M	0.6%	+10.9%	1.491%
11/15/2023	RA Capital Management L.P.	6,718,483	$17.13M	0.3%	+10.7%	9.864%
11/15/2023	GSA Capital Partners LLP	363,493	$0.93M	0.1%	+194.5%	0.534%
11/14/2023	Pale Fire Capital SE	28,100	$72K	0.0%	N/A	0.041%
11/13/2023	Acadian Asset Management LLC	104,069	$0.26M	0.0%	+501.6%	0.153%
11/13/2023	FMR LLC	3,186,751	$8.13M	0.0%	-15.1%	4.679%
11/7/2023	Barclays PLC	249,558	$0.64M	0.0%	+2,635.8%	0.368%
11/7/2023	Jump Financial LLC	14,600	$37K	0.0%	-34.5%	0.022%
10/27/2023	TD Asset Management Inc	219,932	$0.56M	0.0%	+100.0%	0.324%
10/13/2023	SG Americas Securities LLC	21,113	$54K	0.0%	N/A	0.031%
9/21/2023	Barclays PLC	9,122	$54K	0.0%	-69.6%	0.013%
8/14/2023	Casdin Capital LLC	6,381,377	$37.46M	3.3%	+5.0%	9.404%
8/11/2023	Regents of The University of California	16,633	$98K	0.0%	-98.3%	0.025%
8/9/2023	TD Asset Management Inc	109,966	$0.65M	0.0%	-4.3%	0.164%
8/7/2023	Acadian Asset Management LLC	17,300	$0.10M	0.0%	-40.2%	0.026%
7/25/2023	Raymond James & Associates	10,000	$59K	0.0%	N/A	0.015%
7/21/2023	Atticus Wealth Management LLC	83,438	$0.49M	0.2%	N/A	0.125%
7/18/2023	Denali Advisors LLC	51,100	$0.30M	0.1%	N/A	0.076%
7/17/2023	Mesirow Financial Investment Management Inc.	28,784	$0.17M	0.7%	N/A	0.043%
6/1/2023	Prelude Capital Management LLC	25,059	$71K	0.0%	+139.6%	0.037%
5/5/2023	Regents of The University of California	960,957	$2.74M	0.5%	-40.9%	1.437%
5/3/2023	Integrated Wealth Concepts LLC	15,000	$43K	0.0%	+50.0%	0.022%
4/28/2023	SG Americas Securities LLC	15,442	$44K	0.0%	N/A	0.023%
4/19/2023	Redwood Wealth Management Group LLC	11,100	$32K	0.0%	N/A	0.017%
2/14/2023	RA Capital Management L.P.	6,067,483	$12.20M	0.2%	+278.7%	14.663%
2/14/2023	Susquehanna International Group LLP	20,600	$41K	0.0%	N/A	0.050%
2/13/2023	The Manufacturers Life Insurance Company	41,479	$79K	0.0%	-13.5%	0.100%
2/7/2023	TD Asset Management Inc	114,930	$0.23M	0.0%	+86.4%	0.278%
11/16/2022	Alphabet Inc.	915,705	$2.66M	0.1%	N/A	2.213%
11/14/2022	RA Capital Management L.P.	1,602,009	$4.65M	0.1%	-54.9%	3.873%
11/7/2022	Jump Financial LLC	20,800	$60K	0.0%	N/A	0.050%
11/3/2022	Barclays PLC	8,960	$26K	0.0%	+539.1%	0.022%
11/3/2022	Regents of The University of California	1,626,750	$4.72M	1.0%	N/A	3.932%
8/16/2022	Woodline Partners LP	200,698	$1.13M	0.0%	+434.2%	0.485%
8/16/2022	Commodore Capital LP	357,699	$2.01M	0.4%	-30.4%	0.865%
7/29/2022	SG Americas Securities LLC	10,538	$59K	0.0%	N/A	0.026%
6/30/2022	Amalgamated Bank	2,473	$29K	0.0%	N/A	0.006%
5/16/2022	Deep Track Capital LP	546,923	$6.44M	0.4%	-28.3%	1.324%
5/10/2022	TD Asset Management Inc.	61,644	$0.73M	0.0%	+74.7%	0.149%
5/5/2022	New York State Common Retirement Fund	22,585	$0.27M	0.0%	+87.6%	0.055%
2/14/2022	Deep Track Capital LP	762,317	$14.45M	1.0%	N/A	1.847%
2/10/2022	TD Asset Management Inc.	35,278	$0.67M	0.0%	+16.4%	0.085%
2/8/2022	Northern Trust Corp	139,873	$2.65M	0.0%	+13.5%	0.339%
2/2/2022	New York State Common Retirement Fund	12,038	$0.23M	0.0%	+401.6%	0.029%
2/2/2022	DekaBank Deutsche Girozentrale	14,000	$0.27M	0.0%	N/A	0.034%
1/28/2022	Allspring Global Investments Holdings LLC	17,254	$0.33M	0.0%	N/A	0.042%
11/16/2021	Metropolitan Life Insurance Co NY	4,431	$92K	0.0%	N/A	0.011%
11/16/2021	Commodore Capital LP	513,930	$10.61M	2.8%	N/A	1.245%
11/16/2021	Casdin Capital LLC	3,586,818	$74.07M	1.8%	N/A	8.689%
11/15/2021	RTW Investments LP	2,458,750	$48.58M	0.7%	N/A	5.956%
11/15/2021	RA Capital Management L.P.	3,551,508	$73.34M	1.0%	N/A	8.603%
11/15/2021	Trustees of Columbia University in the City of New York	291,828	$6.03M	9.2%	N/A	0.707%
11/15/2021	Caas Capital Management LP	50,000	$1.03M	0.0%	N/A	0.121%
11/15/2021	Harvard Management Co. Inc.	673,270	$13.90M	0.8%	N/A	1.631%
11/15/2021	Jasper Ridge Partners L.P.	43,395	$0.90M	0.0%	N/A	0.105%
11/12/2021	Ghisallo Capital Management LLC	15,000	$0.31M	0.0%	N/A	0.036%
11/12/2021	StepStone Group LP	462,163	$10.68M	0.7%	N/A	1.120%
11/12/2021	Geode Capital Management LLC	215,963	$4.46M	0.0%	N/A	0.523%

Data available starting January 2016

Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through gene editing, cellular regeneration, and gene addition. The company is developing TN-201, a gene therapy for myosin binding protein C3-associated hypertrophic cardiomyopathy which is in phase 1 clinical trial; TN-301, a small molecule for heart failure with preserved ejection fraction which is in phase 1 clinical trial; and TN-401, a gene therapy for plakophilin 2-associated arrhythmogenic right ventricular cardiomyopathy which is in preclinical stage. It also develops an adeno-associated virus-based gene therapy designed to deliver the dworf gene for patient with dilated cardiomyopathy; and reprogramming program for heart failure due to prior myocardial infarction. Tenaya Therapeutics, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.

Today's Range

Now: $2.06

$2.03

$2.26

50 Day Range

MA: $2.01

$1.64

$2.76

52 Week Range

Now: $2.06

$1.61

$7.01

Volume

3,671,635 shs

Average Volume

847,547 shs

Market Capitalization

$163.19 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.34

Who are the company insiders with the largest holdings of Tenaya Therapeutics?: Tenaya Therapeutics' top insider shareholders include:
Group Gp Lp Column III (Major Shareholder)
David V Goeddel (Director)
Deepak Srivastava (Director)
Timothy Hoey (Insider)
Faraz Ali (CEO)
Whittemore Tingley (Insider)
Chihiro Saito (SVP)
Learn More about top insider investors at Tenaya Therapeutics.
Who are the major institutional investors of Tenaya Therapeutics?: Tenaya Therapeutics' top institutional investors include:
RA Capital Management L.P. — 8.81%
FMR LLC — 1.70%
Geode Capital Management LLC — 1.64%
State Street Corp — 1.34%
abrdn plc — 0.70%
Jacobs Levy Equity Management Inc. — 0.43%
Learn More about top institutional investors of Tenaya Therapeutics stock.
Which major investors are selling Tenaya Therapeutics stock?: Within the previous quarter, TNYA stock was sold by these institutional investors:
RA Capital Management L.P.
GSA Capital Partners LLP
Cornercap Investment Counsel Inc.
Jane Street Group LLC
Within the last year, company insiders that have sold Tenaya Therapeutics company stock include:
Group Gp Lp Column III (Major Shareholder)
David V Goeddel (Director)
Deepak Srivastava (Director)
Timothy Hoey (Insider)
Learn More investors selling Tenaya Therapeutics stock.
Which major investors are buying Tenaya Therapeutics stock?: During the last quarter, TNYA stock was purchased by institutional investors including:
abrdn plc
Jacobs Levy Equity Management Inc.
Wellington Management Group LLP
Walleye Capital LLC
Geode Capital Management LLC
FMR LLC
SG Americas Securities LLC
XTX Topco Ltd
During the last year, these company insiders have bought Tenaya Therapeutics stock:
Group Gp Lp Column III (Major Shareholder)
David V Goeddel (Director)
Deepak Srivastava (Director)
Learn More investors buying Tenaya Therapeutics stock.